Depending on strict quality assurance system, up-to-date facilities, and advanced process, HUAPONT provides a reliable guarantee of product quality. Huapont’s strategy is to pursue excellence and innovation at all levels, from manufacturing production units to quality systems and customer care.
Huapont has been inspected and approved by US-FDA since 2012. Huapont past the USFDA inspection without 483 tables in September 2015.
This is the confirmation that our cGMP system is state-of-the-art and compliant with the most recent guidelines and validates our strategy of having an excellent system in place serving our partners
Huapont is regularly inspected by: China-CFDA (China Food and Drug Administration) .
Huapont is regularly inspected by: new Zealand-CFDA (new Zealand Food and Drug Administration) .
ASMF for Calcipotriol Anhydrous (Calcipotriene Anhydrous) was approved by Greece
Certificate for Naftifine HCl approved by Russian MOH
Certificate for Naftifine HCl approved by Ukraine
Copyright © 2018 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.